3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Neoplasms, Plasma Cell
14
Recurrence
12
Leukemia
12
Vomiting
11
Lymphoma, Extranodal NK-T-Cell
11
Lymphoma
11
Neoplasms
9
Nausea
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Paraproteinemias
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphohistiocytosis, Hemophagocytic
3
Lung Neoplasms
3
Immunoglobulin Light-chain Amyloidosis
3
Hematologic Diseases
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Blood Protein Disorders
3
Renal Insufficiency
2
Postoperative Nausea and Vomiting
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Interventions
Bupivacaine
4
Pregabalin
3
Ketamine
3
parecoxib
2
Tramadol
2
Injections, Epidural
2
Fentanyl
2
Ethanol
2
Dexmedetomidine
2
Acetaminophen
2
oxycodone-acetaminophen
1
loxoprofen
1
Surveys and Questionnaires
1
Standard of Care
1
Ropivacaine
1
Rehabilitation
1
Radiofrequency Ablation
1
Passive Cutaneous Anaphylaxis
1
Orphenadrine
1
Musculoskeletal Manipulations
1
Morphine
1
Mindfulness-Based Cognitive Therapy
1
Methadone
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Hydromorphone
1
Hydrocodone
1
Hospitals
1
Gabapentin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Agnosia
×
Dexamethasone
×
Clear all
NCT05432934
2023-12-07
TAP-DEX
University of Saskatchewan
Phase 1/2
Unknown
60 enrolled